Gerald Lema - Jun 7, 2023 Form 4 Insider Report for FIBROGEN INC (FGEN)

Role
Director
Signature
/s/ Cecelia Monoarfa-Taime, Attorney-in-fact
Stock symbol
FGEN
Transactions as of
Jun 7, 2023
Transactions value $
$0
Form type
4
Date filed
6/9/2023, 07:53 PM
Previous filing
Jun 21, 2022
Next filing
Jun 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FGEN Common Stock Award $0 +8.29K +40.48% $0.00 28.8K Jun 7, 2023 Direct F1
holding FGEN Common Stock 16.6K Jun 7, 2023 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FGEN Stock Option (Right to Buy) Award $0 +12.7K $0.00 12.7K Jun 7, 2023 Common Stock 12.7K $17.13 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the grant of restricted stock units that vest on the earlier of June 7, 2024 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date.
F2 Options vest on the earlier of June 7, 2024 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date.